OR WAIT null SECS
© 2022 MJH Life Sciences and Optometry Times. All rights reserved.
© 2022 MJH Life Sciences™ and Optometry Times. All rights reserved.
August 22, 2022
New DME treatments aim to extend time between intravitreal injections.
August 19, 2022
A recent clinical trial from the DRCR Retina Network examined a stepped regimen of anti-VEGF drugs bevacizumab and aflibercept.
August 09, 2022
Proper screenings, treatment, management needed for this increasingly prevalent disease.
August 08, 2022
The patient’s ocular history was significant for severe nonproliferative diabetic retinopathy (NPDR) in the right eye (OD) and mild NPDR in the left eye (OS), which had been diagnosed 4 years previously at his last eye exam.
May 30, 2022
The ADA now recommends an individualized approach at diagnosis of diabetes as well as for adults who do not have symptoms to be screened at age 35 years.
March 25, 2022
Addressing common misconceptions can help avoid misconstrued scientific facts
January 25, 2022
Timing is key in reducing the risk of developing vision loss or blindness.
January 13, 2022
ASCENT, RegenXBio’s Phase III clinical trial conducted in partnership with AbbVie, is expected to enroll patients in the United States and Canada, with pivotal trials expected to support BLA submission for RGX-314 in 2024.
January 10, 2022
Dr. Kerry Gelb speaks with Dr. Jay M. Hainie in the second part of their discussion on diabetes of the eye!
January 03, 2022
Black EyeCare Perspective to host third annual IMPACT HBCU event
Online visual acuity test gains FDA clearance
Debunking common ortho-k myths
Recent study evaluates medications associated with AAC glaucoma risk